KR101738605B1 - A composition comprising medical herbs for improving skin problem and manufacturing method thereof - Google Patents
A composition comprising medical herbs for improving skin problem and manufacturing method thereof Download PDFInfo
- Publication number
- KR101738605B1 KR101738605B1 KR1020140152773A KR20140152773A KR101738605B1 KR 101738605 B1 KR101738605 B1 KR 101738605B1 KR 1020140152773 A KR1020140152773 A KR 1020140152773A KR 20140152773 A KR20140152773 A KR 20140152773A KR 101738605 B1 KR101738605 B1 KR 101738605B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- composition
- skin diseases
- improving skin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title description 6
- 235000008216 herbs Nutrition 0.000 title description 2
- 230000005808 skin problem Effects 0.000 title 1
- 206010003645 Atopy Diseases 0.000 claims abstract description 15
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 12
- 239000010440 gypsum Substances 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 8
- 208000024891 symptom Diseases 0.000 claims description 9
- 238000003809 water extraction Methods 0.000 claims description 7
- 241001105098 Angelica keiskei Species 0.000 claims description 3
- 244000246386 Mentha pulegium Species 0.000 claims description 3
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 3
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 235000001050 hortel pimenta Nutrition 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims 3
- 235000007164 Oryza sativa Nutrition 0.000 claims 3
- 235000009566 rice Nutrition 0.000 claims 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 21
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 11
- 206010000496 acne Diseases 0.000 abstract description 11
- 241000411851 herbal medicine Species 0.000 abstract description 10
- 241000219995 Wisteria Species 0.000 abstract description 5
- 241000208340 Araliaceae Species 0.000 abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 239000004745 nonwoven fabric Substances 0.000 description 6
- 206010012438 Dermatitis atopic Diseases 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 201000008937 atopic dermatitis Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 description 4
- 235000002899 Mentha suaveolens Nutrition 0.000 description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 229910052878 cordierite Inorganic materials 0.000 description 4
- JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- 244000061520 Angelica archangelica Species 0.000 description 3
- 240000001810 Angelica gigas Species 0.000 description 3
- 235000018865 Angelica gigas Nutrition 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000011511 Diospyros Nutrition 0.000 description 3
- 244000236655 Diospyros kaki Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000010515 dystocia Diseases 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 1
- HDTODGZKAUQBPM-DVYQMHLFSA-N (3r,4r)-3-[[3-[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]-4-hydroxy-5-methoxyphenyl]methyl]-4-[(3,4-dimethoxyphenyl)methyl]oxolan-2-one Chemical compound C1=C(O)C(OC)=CC(C(O)C(CO)C=2C(=C(OC)C=C(C[C@H]3C(OC[C@@H]3CC=3C=C(OC)C(OC)=CC=3)=O)C=2)O)=C1 HDTODGZKAUQBPM-DVYQMHLFSA-N 0.000 description 1
- ASYBYLYCBSRGRZ-KWCNVUSUSA-N (3r,4r)-4-[[4-[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy-3-methoxyphenyl]methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one Chemical compound C1=C(O)C(OC)=CC(C[C@H]2C(OC[C@@H]2CC=2C=C(OC)C(OC(CO)C(O)C=3C=C(OC)C(O)=CC=3)=CC=2)=O)=C1 ASYBYLYCBSRGRZ-KWCNVUSUSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 241000174622 Aphrodisias Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 240000009300 Apodytes dimidiata Species 0.000 description 1
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000871189 Chenopodiaceae Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 1
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 1
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000110847 Kochia Species 0.000 description 1
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 1
- FENSEPWVGMYKCW-UHFFFAOYSA-N Lappaol A Natural products COc1cc(CC2C(=O)OCC2(C)Cc3cc(OC)c4OC(C(CO)c4c3)c5ccc(O)c(OC)c5)ccc1O FENSEPWVGMYKCW-UHFFFAOYSA-N 0.000 description 1
- PYLYQTVVQXPBIJ-OUZJQUPYSA-N Lappaol A Chemical compound C([C@H]1C(=O)OC[C@@H]1CC=1C=C(C=2O[C@@H]([C@@H](CO)C=2C=1)C=1C=C(OC)C(O)=CC=1)OC)C1=CC=C(O)C(OC)=C1 PYLYQTVVQXPBIJ-OUZJQUPYSA-N 0.000 description 1
- KNSPNZVXPUCWMJ-UHFFFAOYSA-N Lappaol B Natural products C=1C=2C(CO)C(C=3C=C(OC)C(O)=CC=3)OC=2C(OC)=CC=1CC(C(OC1)=O)C1CC1=CC=C(OC)C(OC)=C1 KNSPNZVXPUCWMJ-UHFFFAOYSA-N 0.000 description 1
- KNSPNZVXPUCWMJ-WHNHDLKRSA-N Lappaol B Chemical compound C([C@@H]1[C@H](C(OC1)=O)CC=1C=C(C=2O[C@@H]([C@@H](CO)C=2C=1)C=1C=C(OC)C(O)=CC=1)OC)C1=CC=C(OC)C(OC)=C1 KNSPNZVXPUCWMJ-WHNHDLKRSA-N 0.000 description 1
- ZYOJOPBUBPCEAV-UHFFFAOYSA-N Lappaol C Natural products COc1cc(CC2C(Cc3cc(OC)c(O)c(c3)C(CO)C(O)c4ccc(O)c(CO)c4)COC2=O)ccc1O ZYOJOPBUBPCEAV-UHFFFAOYSA-N 0.000 description 1
- BWOAMGHNXHLWMX-BAOMQRJLSA-N Lappaol C Chemical compound C1=C(O)C(OC)=CC(C[C@H]2C(OC[C@@H]2CC=2C=C(C(O)=C(OC)C=2)C(CO)C(O)C=2C=C(OC)C(O)=CC=2)=O)=C1 BWOAMGHNXHLWMX-BAOMQRJLSA-N 0.000 description 1
- DDGWGGQDNDWCHX-UHFFFAOYSA-N Lappaol D Natural products COc1cc(ccc1C)C(O)C(CO)c2cc(CC3C(Cc4ccc(OC)c(OC)c4)COC3=O)cc(OC)c2O DDGWGGQDNDWCHX-UHFFFAOYSA-N 0.000 description 1
- ASYBYLYCBSRGRZ-UHFFFAOYSA-N Lappaol E Natural products C1=C(O)C(OC)=CC(CC2C(OCC2CC=2C=C(OC)C(OC(CO)C(O)C=3C=C(OC)C(O)=CC=3)=CC=2)=O)=C1 ASYBYLYCBSRGRZ-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241001180873 Saposhnikovia divaricata Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040840 Skin erosion Diseases 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 206010006514 bruxism Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940021231 clearskin Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 1
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229930008679 prenylflavonoid Natural products 0.000 description 1
- 150000007951 prenylflavonoids Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명에 따르면, 방풍, 고삼, 우방자, 당귀, 선태, 창출, 목통, 생지황, 석고, 백선피, 지부자, 형개 및 박하로 이루어진 혼합 한약재의 추출물을 포함하는 피부질환 개선용 조성물을 제공하며, 본 발명의 한약재를 이용한 피부질환 개선용 조성물 및 그 제조방법에 따르면, 본 발명의 한약재를 이용한 피부질환 개선용 조성물은 피부 질환, 특히 아토피 및 여드름을 부작용 없이 한의학적으로 치료하는데 효과가 있다.According to the present invention, there is provided a composition for improving skin diseases comprising an extract of a mixed medicinal herb consisting of a windbreak, a ginseng, a wisteria, a ginseng, a ginseng, a ginseng, a ginseng, a raw ginseng, a gypsum, a gypsum, According to the composition for improving skin diseases using the herbal medicines of the present invention and the method for preparing the same, the composition for improving skin diseases using the medicinal herb of the present invention is effective for treatment of skin diseases, especially atopic and acne, without any side effects.
Description
본 발명은 한약재 추출물을 포함하는 피부질환 개선용 조성물 및 그 제조방법에 관한 것이다.
The present invention relates to a composition for improving skin diseases comprising a medicinal herb extract and a process for producing the same.
환경 오염, 식생활 습관 및 유전적인 원인 등으로 피부 트러블 및 피부질환 환자수가 계속적으로 증가하고 있으며, 미국의 경우 전 인구의 5∼12 %가 피부질환으로 고통 받고 있고 우리나라의 경우에도 약 200∼300만 명의 피부질환 환자가 있다.
The number of skin troubles and skin disease patients is continuously increasing due to environmental pollution, eating habits and genetic causes. In the United States, 5 ~ 12% of the whole population suffer from skin disease, and in Korea, about 200 ~ 3 million There are patients with skin diseases.
비교적 흔한 피부질환에는 아토피 피부염, 접촉피부염, 지루성 피부염, 두드러기, 무좀, 완선, 건선, 단순· 대상포진, 피부건조증, 주부습진, 여드름 등이 있다.
The most common skin diseases are atopic dermatitis, contact dermatitis, seborrheic dermatitis, urticaria, athlete's foot, rash, psoriasis, simple herpes zoster, dry skin, housewife eczema and acne.
피부질환 중, 특히 아토피피부염 (atopic dematitis, AD)은 만성 피부질환으로 유전적인 요소와 감염이나 음식알레르기 또는 공기의 항원과 같은 환경적인 요소가 복합적으로 작용하며, 심한 가려움증과 습진을 동반하는 재발성 질환으로, 주로 미국, 프랑스 등 선진국에서 발병률이 높으며, 국내에서도 유아와 소아에게서 높은 발병률을 보이고 있다.
Among the skin diseases, especially atopic dematitis (AD), chronic skin disease is a combination of genetic factors and environmental factors such as infection, food allergy or air antigen, and is associated with severe itching and eczema The incidence is high in developed countries such as the United States and France, and has a high incidence in infants and children in Korea.
최근 들어 이 질환의 급격한 증가는 유전적 소인만으로는 설명이 어렵고 산업화, 주거 형태, 식습관의 서구화 및 핵가족화 등 환경적 요인의 중요성이 특히 강조되고 있으며, 이러한 다양한 원인에 노출될 위험도 증가하고 있는 실정이다.
In recent years, the rapid increase of the disease has been difficult to explain only by genetic sequencing, and the importance of environmental factors such as industrialization, residential type, westernization of eating habit and nuclear family has been emphasized, and the risk of exposure to various causes is increasing .
한편, 아토피피부염 환자들은 특정 항원에 감작되면, 인체 내에서 여러 인자들을 생산하고 조절하게 되며, 염증반응에서 대표적으로 작용하는 대식세포 (Macrophage)가 외부 인자에 감염되면 NO 및 다양한 사이토카인을 생산하는데, 분비된 사이토카인은 염증에 관여하는 면역세포를 활성화 시킨다.
If atopic dermatitis patients are sensitized to specific antigens, they produce and control various factors in the human body. Macrophages, which are typical for inflammatory reactions, produce NO and various cytokines when they are infected with external factors , Secreted cytokine activates immune cells involved in inflammation.
특히 아토피피부염환자에서는 특징적으로 Immunoglobulin E (IgE)의 생산을 유도하고 IgE-수용체의 발현을 상승 시키게 된다. 과도한 IgE의 생산은 IgE-의존 히스타민 반응에 의해 비만세포를 자극하여 과도한 히스타민 방출을 유도한다.In particular, in patients with atopic dermatitis, the production of immunoglobulin E (IgE) is characteristic and the expression of IgE-receptor is elevated. Excessive production of IgE stimulates mast cells by IgE-dependent histamine reactions leading to excessive histamine release.
히스타민은 심한 가려움증을 유발하며, 환자들의 긁는 행위로 인하여 2 차적 감염이 일어나 영향염증과 아토피피부염으로 발전하여, 환자들에게 큰 고통을 주고 있다.
Histamine causes severe itching, and secondary infections are caused by scratching of patients, resulting in inflammation and atopic dermatitis.
그럼에도 불구하고 현재 그 치료제나 개선제로는 심각한 부작용을 나타내는 스테로이드 제제가 대부분이고, 최근에는 면역억제제가 개발되어 있으나, 아직까지는 부작용 염려 없이 완치 효과를 발휘하는 특별한 치료제나 개선제는 개발되어 있지 않은 실정이다.
Nevertheless, most of the current therapeutic agents and remedies are steroids, which show serious side effects. Recently, immunosuppressive drugs have been developed, but no specific therapeutic agents or remedies have yet been developed that exhibit a cure effect without worrying about side effects .
또한, 스테로이드제 이외에도 현재 항염증 또는 피부질환 치료효과 등에 알려진 생약들의 유효성분을 추출하여 피부질환 치료제로 개발된 예들이 알려져 있으나, 대부분 가려움증이나 염증 등을 경감시켜 줄 뿐이어서 그 치료효과가 미미한 문제점이 있어 실제로는 그 적용에 한계가 있는 실정이다.
In addition to steroids, there have been known examples of therapeutic agents for treating skin diseases by extracting active ingredients of herbal medicines currently known for their antiinflammatory or skin disease treatment effects. However, most of them have relieved itching and inflammation, There is a limit to its application.
이처럼, 아직까지 부작용이 적으면서도 우수한 효과를 발휘하는 예방 또는 치료목적의 한방제제는 개발되지 않아 심각한 부작용을 나타내는 스테로이드 제제가 대부분 사용되고 있다. 또한, 최근에는 면역억제제가 피부질환 치료제로 개발되어 사용되기도 하였는데, 이런 제제는 면역기능 저하, 피부위축, 어린이 성장방해, 모세혈관 확장, 여드름, 부신피질기능 억제 등의 부작용이 수반되기 때문에 임상적 사용에 매우 주의해야 하는 문제점이 있다.
Thus, herbal preparations for preventive or therapeutic purposes, which have little side effects and yet exhibit excellent effects, have not been developed, and most of the steroid preparations exhibiting serious side effects are used. In recent years, immunosuppressive agents have been developed and used as therapeutic agents for skin diseases. These agents have been known to have clinical effects due to immunosuppression, skin atrophy, inhibition of growth of children, capillary vasodilation, acne, There is a problem to be very careful in use.
따라서 상기한 바와 같은 문제점들을 해결하는 부작용이 없으면서 아토피 및 여드름과 같은 피부질환을 효과적으로 치료할 수 있는 조성물의 개발이 필요하다.
Therefore, there is a need to develop a composition capable of effectively treating skin diseases such as atopy and acne without the side effects of solving the above-mentioned problems.
본 발명의 목적은, 피부 질환, 특히 아토피 및 여드름의 예방 및 치료에 효능이 있는 한약재를 유효성분으로 포함하여 부작용이 없는 피부질환 개선용 조성물 및 그 제조방법의 제공을 목적으로 한다.
It is an object of the present invention to provide a composition for improving skin diseases and a method for producing the same, which is free from side effects by containing a herbal medicine which is effective for the prevention and treatment of skin diseases, particularly atopic and acne.
상기 목적을 달성하기 위하여, 본 발명에 따른 피부질환 개선용 조성물은 방풍, 고삼, 우방자, 당귀, 선태, 창출, 목통, 생지황, 석고, 백선피, 지부자, 형개 및 박하로 이루어진 혼합 한약재의 추출물을 포함하는 것을 특징으로 한다.
In order to attain the above object, the composition for improving skin diseases according to the present invention is characterized by comprising an extract of a mixed medicinal herb consisting of windblown, gossam, wisteria, angelica gigas, pickled ginseng, gypsum, raw persimmon, gypsum, white line, .
또한, 본 발명에 따른 피부질환 개선용 조성물은 상기 방풍, 고삼, 우방자, 당귀, 선태, 창출, 목통, 생지황, 석고, 백선피, 지부자, 형개 및 박하의 혼합 한약재 추출물이 방풍 1 ~ 10 중량부, 고삼 1 ~ 10 중량부, 우방자 1 ~ 10 중량부, 당귀 1 ~ 10 중량부, 선태 1 ~ 10 중량부, 창출 1 ~ 10 중량부, 목통 1 ~ 10 중량부, 생지황 1 ~ 10 중량부, 석고 1 ~ 10 중량부, 백선피 1 ~ 10 중량부, 지부자 1 ~ 10 중량부, 형개 1 ~ 10 중량부 및 박하 1 ~ 10 중량부인 것을 특징으로 한다.
The composition for improving skin diseases according to the present invention may further comprise 1 to 10 parts by weight of a mixture of the herbal medicines extract of Braun, Gossam, Wisteria, Angelica keiskei, 1 ~ 10 parts by weight of corn steep liquor, 1 ~ 10 parts of corn steep liquor, 1 ~ 10 parts of corn steep liquor, 1 ~ 10 parts of corn steep liquor, 1 ~ 10 parts of corn steep liquor, 1 ~ 1 to 10 parts by weight of gypsum, 1 to 10 parts by weight of a white line, 1 to 10 parts by weight of a support, 1 to 10 parts by weight of a mold, and 1 to 10 parts by weight of a mint.
또한, 본 발명에 따른 피부질환 개선용 조성물은 상기 혼합 한약재의 추출물이 열수추출하여 얻어진 것을 특징으로 한다.
In addition, the skin disease-improving composition according to the present invention is characterized in that the extract of the mixed medicinal herb is obtained by hot water extraction.
또한, 본 발명에 따른 피부질환 개선용 조성물은 정제, 캡슐제, 환제 또는 액제인 것을 특징으로 한다.
In addition, the composition for improving skin diseases according to the present invention is characterized by being a tablet, a capsule, a pill or a solution.
또한, 본 발명에 따른 피부질환 개선용 조성물은 아토피 및 여드름에 치료효과가 있는 것을 특징으로 한다.
In addition, the composition for improving skin diseases according to the present invention is characterized by having a therapeutic effect on atopy and acne.
본 발명에 따른 한약재를 이용한 피부질환 개선용 조성물에 따르면, 본 발명의 한약재를 이용한 피부질환 개선용 조성물은 피부 질환, 특히 아토피 및 여드름을 부작용 없이 한의학적으로 치료하는데 효과가 있다.
According to the composition for improving skin diseases using the medicinal herb according to the present invention, the composition for improving skin diseases using the medicinal herb of the present invention is effective for treating the skin diseases, especially atopy and acne without any side effects.
도 1은 본 발명의 열수추출에 의한 피부질환 개선용 조성물의 제조 방법을 나타내는 흐름도이다. BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a flowchart showing a method for producing a skin disease-improving composition by hot water extraction of the present invention.
본 발명에 따른 피부질환 개선용 조성물은 방풍, 고삼, 우방자, 당귀, 선태, 창출, 목통, 생지황, 석고, 백선피, 지부자, 형개 및 박하로 이루어진 혼합 한약재의 추출물을 포함한다.
The composition for improving skin diseases according to the present invention includes an extract of a mixed medicinal herb consisting of windblown, gosang, wisteria, angelica, senbetsu, kiwon, bamboo, bamboo leaf, gypsum, white pear, placer, mold and mint.
여기서, 상기 한약재 조성물은 총 중량에 대하여 상기 방풍 1 ~ 10 중량부, 고삼 1 ~ 10 중량부, 우방자 1 ~ 10 중량부, 당귀 1 ~ 10 중량부, 선태 1 ~ 10 중량부, 창출 1 ~ 10 중량부, 목통 1 ~ 10 중량부, 생지황 1 ~ 10 중량부, 석고 1 ~ 10 중량부, 백선피 1 ~ 10 중량부, 지부자 1 ~ 10 중량부, 형개 1 ~ 10 중량부 및 박하 1 ~ 10 중량부의 추출물의 중량비로 포함하는 것이 바람직하다.
Herein, the herbal composition comprises 1 to 10 parts by weight of the above-mentioned windshield, 1 to 10 parts by weight of Gossam, 1 to 10 parts by weight of Gossamer, 1 to 10 parts by weight of Angelica keiskei, 1 to 10 parts by weight of Gossamer, 1 to 10 parts by weight 1 to 10 parts by weight of green tea beans, 1 to 10 parts by weight of green tea beans, 1 to 10 parts by weight of gypsum, 1 to 10 parts by weight of white line, 1 to 10 parts by weight of green tea, 1 to 10 parts by weight of molds, By weight of the extract in parts by weight.
여기서, 상기 각 한약재 성분의 중량부는 본 발명의 발명자가 한의사로서 실제 다년간의 임상 실험을 통해 가장 효과가 좋은 것으로 나타난 것을 도출해낸 것이며, 동일하거나 유사한 효능을 내기 위하여 해당 수치로 한정됨을 의미하는 것은 아니다.
Herein, the weight portion of each of the herbal ingredients is derived from the inventor of the present invention as the best practitioner through many years of clinical trials, and does not mean that the herbal composition is limited to the numerical value for the same or similar efficacy .
본 발명에 따른 피부질환 개선용 조성물을 구성하는 각각의 한약재의 중량비 범위는 개선효과와 부작용 가능성을 기준으로 한정된 것으로, 중량비 범위의 상한값은 다른 한약재들의 함량을 전체적으로 고려하여 결정되었고 중량비 범위의 하한값은 그 이하에서는 피부질환(특히, 아토피 및 여드름)의 개선효과가 떨어지는 문제가 있어, 본 발명에 따른 조성물을 구성하는 각각의 한약재의 중량비 범위는 상술한 바와 같은 수치범위로 한정하였다.
The weight ratio of each medicinal herb constituting the composition for improving skin diseases according to the present invention is limited on the basis of the improvement effect and the possibility of side effects. The upper limit value of the weight ratio range is determined considering the contents of other medicinal materials as a whole, There is a problem that the improvement effect of skin diseases (especially, atopic and acne) is lowered, and the weight ratio range of each herbal medicine constituting the composition according to the present invention is limited to the above-mentioned numerical range.
다음으로, 상기 피부질환 개선용 조성물에 사용되는 한약재를 간략하게 소개한다.
Next, the herbal medicine used in the composition for improving skin diseases will be briefly introduced.
방풍(Saposhnikovia divaricata Schiskin:防風)은 산형과의 방풍의 뿌리 및 뿌리줄기를 사용해 만든 약재 방풍으로, 풍을 막아 준다는 뜻으로 풍병(風病)을 치료하는데 있어서 매우 중요한 약재이다. 방풍은 원주모양을 하고 있으며 아래쪽은 약간 가늘다. 바깥면은 엷은 갈색을 띠며 뿌리줄기의 윗부분에는 촘촘히 돌림마디모양의 세로 주름이 있고 갈색의 털모양으로 된 엽초의 잔기가 붙어 있는 것도 있다. 외감성 두통, 오한, 발열, 전신통, 인후통 등 모든 풍증(風症)에 효과가 있다.
The windshield (Saposhnikovia divaricata Schiskin: windbreak) is a medicinal windshield made of roots and rootstocks of mountain-type windshields and is a very important medicinal material for the treatment of windshields (winds disease). The windshield is cylindrical and the lower part is slightly thinner. The outer surface is light brown, and the upper part of the rootstock has dense wrinkles in the form of rounded nodules, and some of the hairy leaves of brown hair are attached. It is effective for all kinds of aphrodisias such as external headache, chills, fever, whole body and sore throat.
고삼(苦蔘, Sophorae Radix)은 콩과에 속하는 다년생초본인 도둑놈의 지팡이(Sophora angustifolia S. et. Z) 뿌리의 코르크층을 제거하여 건조시킨 것으로서(김창민 외, 중약대사전, 1권, pp340-347, 1997, 도서출판 정담, 서울), 예로부터 고미건위약으로 적리, 장출혈, 치질 등에 사용되어 왔다. 또한, 상기 고삼으로부터 다양한 종류의 알칼로이드, 프레닐 플라보노이드, 트리테르펜 등의 성분이 분리되었고, 상기 성분들은 항부정맥 작용, 항궤양 활성, 항천식 활성, 항균작용, 항바이러스 활성, 암세포에 대한 세포독성 등의 작용이 보고되어 있으며, 피부염, 아토피, 여드름에 효과적이다.
Sophorae Radix is a herbaceous perennial herbaceous rod (Sophora angustifolia S. et. Z) that has been dried by removing the cork layer from the roots (Kim Chang Min et al., Chinese Medicine Dictionary, Vol. 1, pp340- 347, 1997, published by Seongdam, Seoul), has been used for a long time as a placebo, intestinal hemorrhage, and hemorrhoids. In addition, various kinds of alkaloids, prenyl flavonoids, triterpene and the like components were separated from the ginseng, and the components were classified into antiarrhythmic activity, anti-ulcer activity, anti-asthmatic activity, antimicrobial activity, antiviral activity, Have been reported, and are effective in dermatitis, atopy, and acne.
우방자(牛蒡子, Arctii Fructus)는 우엉(Arctium lappa Linne)의 종자로서, 악틴(arctin), 라파올 A, B, C, D, E(lappaol A, B, C, D, E), 악티게닌(arctigenin), 아락티딕 산(aractidic acid) 등을 함유하며, 해독(解毒)·소염(消炎)·배농(排膿)의 효과가 있으며, 화농성(化膿性) 종기, 피부병 등에 쓰이는 경우가 많고, 감기, 인후통, 편도선염 등의 치료에도 응용한다.
Arcti Fructus is a seed of Arctium lappa Linne and contains arctin, raffol A, B, C, D and E (lappaol A, B, C, D and E) arctigenin and aractidic acid and has the effect of detoxification, quenching and drainage. It is often used for purulent boils and skin diseases, It is also applied to the treatment of cold, sore throat and tonsillitis.
당귀(Angelica gigas)는 미나리과(Umbelliferae)에 속하는 다년생 초본으로, 참당귀의 근에는 데커신(decursin), 데커시놀(decursinol), 뿌리에는 임페라토린(imperatorin)이 함유되어 있고, 이는 거풍(祛風), 화혈(和血), 보혈(補血), 구어혈(驅瘀血), 강장(剛腸), 조경(調經), 진정(鎭靜) 등의 효능이 있다.
Angelica gigas is a perennial herb belonging to Umbelliferae. It contains decursin, decursinol and imperatorin in the root of Angelica gigas Nakai, (风 風), blood (驅 瘀 血), blood (补血), 补血 (驅 瘀血), the gangjang (剛 肠), the landscape and the calm (鎭 静) is the efficacy.
선태는 선퇴각(蟬退殼), 선퇴(蟬退), 선의(蟬衣), 선갑(蟬甲), 선각(蟬殼) 및 고선(枯蟬)이라는 이름으로 불리며, 맛은 달(甘)고 간(肝)과 폐(肺)에 작용한다. 약리효과는 소아의 경간(驚癎)을 치료하고 난산(難産)을 치료한다. 약재를 태운 재를 물로 복용하면 오래된 이질(痢疾)을 치료하며 소아가 고열로 경련이 발생하는 것을 치료하며 갈증을 그치게 하고 분말 1전(錢)을 정화수(井華水)로 복용하면 목소리가 나오지 않는 증상을 치료한다고 알려져 있다.
It is called the retirement of the line, retirement, goodness, 蟬 甲, 蟬 및 and 蟬 蟬, and the taste is moon, It acts on the liver (liver) and lung (lung). The pharmacological effect heals the spine of children and treats dystocia (dystocia). Taking ashes of medicinal materials with water will cure old diarrhea, cure the occurrence of seizures in children with high fever, stop the thirst, and take a powder 1 (钱) with Junghwa (井 華 水). It is known to treat symptoms that do not exist.
창출은 국화과에 속한 다년색 초본인 삽주의 근경을 건조한 것으로 비위의 습사를 화습시키므로 조습건비시키는 요약이 되는 약이다.
Creation is a medicine that summarizes the drying of the rhizome of a multi-year-old herbaceous plant belonging to the Asteraceae family, and it is a summarizing remedy for the irritation of the abdomen.
목통은 으름덩굴과에 속한 낙엽 전요관목인 으름의 목질경을 건조한 것으로 아케보사이드 11종이 함유되어 있으며 강화이뇨의 효능이 강한 약재이다
The throat is a dry leaf of the forest of the dead tree which belongs to the vine of the vine of the shrubs. It contains 11 kinds of acne vine and is a medicinal substance with the effect of strengthened diuretic.
생지황(Rehmanniae Radix)은 지황 또는 그 밖의 동속 식물(현삼과 Scrophulariaceae)의 신선한 뿌리이며, 생진지갈(生律止渴)하여 생기는 설홍구건(舌紅口乾) 번갈다음(煩渴多飮)에 좋다.
Rehmanniae Radix is a fresh roots of rhubarb or other scrophulariaceae, and it is found in the 渴渴渴 다음 다음 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 번 good.
석고(石膏)는 폐위(肺胃)의 기분열(氣分熱)을 없애고 혈약(血藥)을 도와 양혈해독(凉血解毒)하기 때문에, 울폐(鬱閉)하여 된 발진(發疹)과 사열(邪熱)이 영혈(營血)에까지 파급된 발반(發斑)에 사용할수 있다.
Because gypsum removes the mood of lung from the lungs and helps blood 药 to detoxify the blood, it causes dyspepsia and eruption, It can be used for the spreading of the fever (肝热) to the blood (胆 血).
백선피는 운향과(Rutaceae) 식물인 백선(Dictamnus dasycarpus)의 뿌리 껍질을 말한다(대한약전외한약(생약)규격집(KHP), 2007). 백선피는 청열해독, 거습지통의 효능이 있어 피부발진, 피부미란, 습진, 풍진, 가려움증, 황달, 뇨적, 사지마비, 해수, 인후건조, 번갈 등의 증상을 치료하는데 활용할 수 있다고 알려져 있다.
It refers to the roots of Dactamnus dasycarpus, a Rutaceae plant (Korean Pharmacopoeial Species (KHP), 2007). It is known that it can be used to treat symptoms such as skin rash, skin erosion, eczema, rubella, itching, jaundice, urinary tract, limb paralysis, seawater, throat drying,
지부자(地膚子)는 명아주과(Chenopodiaceae)에 속하는 일년생 초본인 댑싸리(Kochia scoparia SCHRAD.)의 성숙한 열매를 건조한 것으로, 가을에 과실이 성숙하였을 때 베어 건조 후, 껍질을 제거하여 사용한다. 약간의 향기가 있고 맛은 조금 쓰며, 주요성분은 triterpenoid saponin과 정유 성분을 15% 함유하며, 녹색 부분에는 alkaloid가 함유되어 있다. 지부자는 청열이습(熱利), 거풍지양(祛風止痒), 치소변삽통(治小便痛) 등 이뇨작용이나 피부진균의 억제 작용이 있다고 알려져 있다.
The buddha is a mature fruit of the annual herbaceous Kochia scoparia SCHRAD. Belonging to the Chenopodiaceae. It dries when the fruit grows in autumn, and then removes the skin after drying. It has a little scent and a little bit of taste. Its main ingredient contains triterpenoid saponin and 15% essential oil, and the green part contains alkaloid. It is known that the supporters have diuretic action and inhibition of skin fungi such as blue fever, bruxism, and urinary incontinence.
형개는 꿀풀과(Lamiaceae)에 속하는 1 년생 풀이며 중국이 원산지로 약용식물로 전국에서 재배한다. 꽃 이삭이 달린 가지와 줄기를 말린 것을 형개 또는 가소라고 하여 거풍해표(祛風解表), 감기의 발열, 인후종통, 마진(麻疹), 산후의 중풍, 육혈, 대하증 등에 사용하고 지혈제·진경제로도 쓴다.
The mold is a 1-year-old grass belonging to the Lamiaceae, and is cultivated nationwide as a medicinal plant originating in China. It is used as a bamboo shrimp (祛風 解 表), fever of the cold, throat dandruff, margin (measles), postpartum paralysis, hemorrhage, I also write.
박하는 꿀풀과(Lamiaceae)에 속하는 다년생 풀로 날씨가 좋은 날 잎을 따서 그늘에 말린 것을 박하라고 하여 해열제나 건위제로 쓰기도 하는데, 이보다는 잎에 들어 있는 멘톨(menthol)을 치약·향료·과자·음료수 등에 넣어 방향제로 널리 쓰고 있다.
Mint is a perennial grass belonging to the Lamiaceae. It is used as an antipyretic agent or as a dry noodle for peppermint, which is dried in the shade after the leaves of a good day. The menthol contained in the leaves is used as toothpaste, spices, It is widely used as a fragrance in beverages.
본 발명의 발명자는 수년간의 임상 실험의 결과, 각각의 약재가 개별적으로 사용될 때에 비해, 특정 조합으로 사용될 경우 더욱 즉각적이고 분명한 피부질환 개선 효과 등을 나타내는 것을 검증하였다.
The inventors of the present invention have verified that as a result of several years of clinical trials, when each of the medicaments is used individually, it shows a more immediate and clear skin disease improvement effect when used in a specific combination.
각 성분의 상호 작용, 즉 함께 섭취된 성분의 약리 효과를 상승시킨다거나, 특정 성분이 가진 효과의 부족한 부분을 보충하는 등의 작용에 의해 일어나는 것으로 판단되며, 이러한 결과는 이후 임상 실험에 따른 대조군의 설문 조사 결과에서 분명하게 드러날 것이다.
It is judged that this is caused by the action of each component, that is, by raising the pharmacological effect of the components taken together, or supplementing the deficient part of the effect of the specific component. The results of the survey will be clear.
본 발명의 조성물은 약학적 조성물일 수 있으며, 경구 또는 비경구 어느 수단으로라도 투여할 수 있다. 투여 제형에는 특별한 제한은 없지만, 환자의 연령, 성별 또는 질환의 경중뿐만 아니라 제형에 따라 결정될 것이다.
The composition of the present invention may be a pharmaceutical composition, and may be administered either orally or parenterally. The dosage form is not particularly limited, but will be determined depending on the age, sex, or the severity of the disease as well as the dosage form of the patient.
또한, 본 발명의 조성물은 피부질환 특히, 아토피 및 여드름의 예방 및 치료 를 목적으로 하는 건강식품일 수 있다. 본 발명에 따른 한약재 추출물들을 식품 첨가물로 사용할 경우, 상기 한약재 추출물들을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 사용 목적 즉, 예방, 건강 또는 치료 목적 등에 따라 적합하게 결정될 수 있으며, 정제, 캡슐제, 환제 또는 액제 등의 형태로 제조할 수 있다.
In addition, the composition of the present invention may be a health food for the prevention and treatment of skin diseases, especially atopic and acne. When the herbal extracts according to the present invention are used as a food additive, the herbal extracts may be directly added or used together with other food or food ingredients, and may be suitably used according to a conventional method. The amount of the active ingredient to be mixed may be suitably determined according to the purpose of use, that is, prevention, health, or therapeutic purpose, and may be in the form of tablets, capsules, pills, or liquids.
예를 들어, 상기 조성으로 이루어진 혼합 한약재의 추출물을 포함하는 피부질환 개선용 조성물은 상기 한약재를 채취하여 물, 에탄올, 부탄올 및 메탄올과 같은 극성용매 및 에테르, 헥산, 벤젠, 클로로포름 및 에틸아세테이트 등의 비극성 용매를 가하여 실온에서 침적 추출하거나 가온 추출할 수 있다. 바람직하게는, 본 발명의 조성물은 열수 추출방법에 의해 제조할 수 있다.
For example, a composition for improving skin diseases comprising an extract of a mixed medicinal herb comprising the above composition may be prepared by taking the medicinal herb and dissolving it in a polar solvent such as water, ethanol, butanol and methanol, and a polar solvent such as ether, hexane, benzene, chloroform and ethyl acetate Nonpolar solvent may be added and the mixture may be precipitated at room temperature or warm-extracted. Preferably, the composition of the present invention can be prepared by a hot water extraction method.
상기 열수 추출방법은 공지된 방법을 사용하여 제조할 수 있으나, 바람직하게는 도 1에 나타난 열수추출에 의한 피부질환 개선용 조성물의 제조방법을 나타내는 흐름도에 따라 제조될 수 있다. 도면에 나타낸 바와 같이, 본 발명에 따른 열수추출에 의한 피부질환 개선용 조성물의 제조방법은 먼저, 방풍 1 ~ 10 중량부, 고삼 1 ~ 10 중량부, 우방자 1 ~ 10 중량부, 당귀 1 ~ 10 중량부, 선태 1 ~ 10 중량부, 창출 1 ~ 10 중량부, 목통 1 ~ 10 중량부, 생지황 1 ~ 10 중량부, 석고 1 ~ 10 중량부, 백선피 1 ~ 10 중량부, 지부자 1 ~ 10 중량부, 형개 1 ~ 10 중량부 및 박하 1 ~ 10 중량부를 포함하는 한약재를 혼합하는 단계(S101)를 거친다.
The hot water extraction method can be prepared by using a known method, but preferably it can be produced according to a flowchart showing a method for producing a skin disease improving composition by hot water extraction shown in FIG. As shown in the figure, the method for preparing a composition for improving skin diseases by hot water extraction according to the present invention comprises: 1 to 10 parts by weight of windshield, 1 to 10 parts by weight of ginseng, 1 to 10 parts by weight, 1 to 10 parts by weight of cordierite, 1 to 10 parts by weight of cordierite, 1 to 10 parts by weight of cordierite, 1 to 10 parts by weight of cordierite, 1 to 10 parts by weight of raw persimmon, 1 to 10 parts by weight of plaster, 1 to 10 parts by weight of a mold, and 1 to 10 parts by weight of a peppermint are mixed (S101).
한약재의 혼합비율은 각각 상기한 바와 같이 첨가하는 것이 바람직하지만, 적용하고자 하는 질환의 종류, 사용자의 연령 등에 따라 일부의 한약재의 사용량은 변경될 수 있다.
The mixing ratios of the herbal medicines are preferably added as described above, but the amount of herbal medicines to be used may vary depending on the type of disease to be applied and the age of the user.
다음으로, 상기 혼합된 혼합물을 부직포에 담아 조제하고, 물이 담긴 약탕기에 넣어 순환식 무압력 상태에서 달이는 단계(S102)를 거친다. Next, the mixed mixture is prepared in a nonwoven fabric, put in a water bath containing water, and subjected to a circulating pressureless state (S102).
보다 구체적으로, 상기 부직포는 탕전용 부직포이며 이에 상기 혼합 한약재를 포함하며, 이를 혼합 한약재 전체 중량에 대하여 추출용매(물)를 2 배 내지 7 배를 포함하는 약탕기에 넣은 상태에서, 강한 불로 가열하여 끓는점(100℃)에 도달할 때까지 물을 끓이는 것이 바람직하다.More specifically, the nonwoven fabric is a hot-water nonwoven fabric, which contains the herbal medicines, and the medicinal herbs are placed in a pottery containing 2 to 7 times of the extraction solvent (water) It is desirable to boil the water until the boiling point (100 ° C) is reached.
또한, 물이 끓고 난 후에는 약한 불에서 2 시간 내지 4 시간 가량을 더 끓여서 한약재의 유효 성분이 충분히 추출될 때까지 달이는 것이 바람직하다.
Further, it is preferable that boiling water is boiled for 2 to 4 hours in a weak fire until the active ingredient of herbal medicine is sufficiently extracted.
아울러, 상기 달여진 약물을 여과하는 단계(S103)를 통해 피부질환 개선에 도움이 되는 탕액을 얻는다.
In addition, the step of filtering the drug (S103) provides a solution for improving skin diseases.
아래에서 본 발명에 대해 실시 예를 기초로 하여 상세하게 설명한다. 제시된 실시 예는 예시적인 것으로 본 발명의 범위를 제한하기 위한 것은 아니다.
Hereinafter, the present invention will be described in detail on the basis of embodiments. The presented embodiments are illustrative and are not intended to limit the scope of the invention.
<< 실시예Example >>
한약재로서 방풍, 고삼, 우방자, 당귀, 선태, 창출, 목통, 생지황, 석고, 백선피, 지부자, 형개 및 박하를 준비하였다.As a medicinal herb, we prepared windblown, gosam, wisteria, angelica, chrysanthemum, chrysanthemum, thistle, balsam, gypsum, white line, branch, chisel and mint.
각각의 한약재는 방풍, 고삼, 우방자, 당귀, 선태, 창출, 목통, 생지황, 석고, 백선피, 지부자, 형개 및 박하를 각각 약 10 g로하며, 엽류 한약재나 얇게 절편으로 가공된 것을 제외한 한약재는 '대한약전' 통칙 19조에 규정된 의약품의 "절도" 및 "분말도" 중 세절(細切)에 준하는 크기로 하였다.
Each medicinal herb has about 10 g each of windbreak, gosam, raveler, angelica, elliptic, creation, throat, raw persimmon, gypsum, plaster, The size of the medicines prescribed in Article 19 of the "Pharmacopoeia" of the "Pharmacopoeia" was the same as the fraction of the "theft" and "powder".
이후, 상기 한약재를 혼합하여 부직포에 담은 후 총 약재 용량의 약 5 - 10배에 해당하는 정수된 물을 약탕기에 담고, 상기 한약재가 담긴 부직포를 침지시킨 후 약 4 시간 동안 100 ℃에서 순환식 무압력 상태로 달였다.
Then, the medicinal materials were mixed and immersed in a nonwoven fabric, and then purified water corresponding to about 5 to 10 times the total medicinal capacity was placed in a pottery, and the nonwoven fabric containing the medicinal herb was immersed therein. Thereafter, It was in a state of pressure.
이후, 조제된 약재를 물에서 정해진 시간 동안 끓인 후 상기 한약재가 담긴 부직포를 제거하여 피부질환 개선용 조성물을 포함한 탕액을 얻었다.
Then, the prepared medicinal material was boiled in water for a predetermined period of time, and the nonwoven fabric containing the medicinal herb was removed to obtain a bath liquid containing a composition for improving skin diseases.
<< 시험예Test Example >>
아토피 피부 질환개선에 대한 효과를 평가하기 위하여 아토피 대상 환자는 성별 및 연령대를 특별히 제한하지 않은 청장년층에 해당하는 지원자 10명에 대하여 실험을 실시하였다. 본 효능 실험에 동의한 환자들의 증상은 대부분 미란, 태선화, 살이 트거나, 붉은 반점이 있고, 가려움증을 포함하는 아토피 증상이 심한 환자들로, 전체 참가자들은 상기 실시 예에서 제조한 탕액을 복용하였다. In order to evaluate the effect of atopic dermatitis on the improvement of atopic skin disease, 10 patients who were at least 20 years old were tested. The patients who agreed to the efficacy test were all suffering from atopic symptoms including erosion, fibrinolysis, redness, red spot, and itching. All the participants took the bath solution prepared in the above example.
이때, 상기 탕액은 한 팩을 100cc로 하여 하루 2회 식 전 30분 쯤에 복용하는 것을 원칙으로 하였다.
At this time, as a rule, the bath solution is taken in a pack of 100 cc for about 30 minutes before the meal twice a day.
[표 1] [Table 1]
상기 표에 나타낸 바와 같이, 실시예에 따라 제조한 탕액을 복용한 참가자들은 복용 전 대부분 미란, 태선화, 살이 트거나, 붉은 반점이 있었으며, 가려움증을 동반하는 아토피 증상이 심한 환자들이었으며, 성별, 연령, 아토피 병력 및 증상부위 등이 다양한 환자들이였다. 그러나, 아토피 증상의 정도에 따라 차이는 있지만 복용시킨 결과 증상이 완화되거나 완치되어 본 발명의 조성물은 아토피 치료 및 완화 효과가 탁월함을 알 수 있었다.
As shown in the above table, the participants taking the bath solution prepared according to the Examples were mostly patients with erosive symptoms accompanied by most erosion, fibrinolytic acidosis, redness, red spot, and itching, and the sex, age , Atopic history, and symptom site. However, although there is a difference depending on the degree of atopic symptoms, the symptom is alleviated or cured as a result of the administration, so that the composition of the present invention is excellent in atopy treatment and relieving effect.
이상에서 본 발명은 특정의 실시 예와 관련하여 도시 및 설명하였지만, 첨부된 특허청구 범위에 의해 나타난 발명의 사상 및 영역으로부터 벗어나지 않는 한도내에서 다양한 변경, 개조, 및 변화가 가능하다는 것을 당 업계에서 통상의 지식을 가진 자라면 누구나 쉽게 알 수 있을 것이다. While the present invention has been particularly shown and described with reference to specific embodiments thereof, it will be understood by those skilled in the art that various changes, modifications, and variations may be made without departing from the spirit and scope of the invention as defined by the appended claims. Anyone with ordinary knowledge will know easily.
Claims (5)
1 to 10 parts by weight of gusts, 1 to 10 parts by weight of ginseng, 1 to 10 parts by weight of glutamate, 1 to 10 parts by weight of Angelica keiskei, 1 to 10 parts by weight of glutinous rice, 1 to 10 parts by weight of glutinous rice, 1 to 10 parts by weight of glutinous rice, 1 to 10 parts by weight of gypsum, 1 to 10 parts by weight of gypsum, 1 to 10 parts by weight of white line, 1 to 10 parts by weight of leaflet, 1 to 10 parts by weight of mold, and 1 to 10 parts by weight of peppermint A composition for relieving symptoms.
상기 혼합 한약재의 추출물은 열수 추출하여 얻어진 것을 특징으로 하는 아토피 증상 완화용 조성물.
The method according to claim 1,
Wherein the extract of the mixed medicinal herb is obtained by hot water extraction.
상기 아토피 증상 완화용 조성물은 정제, 캡슐제, 환제 또는 액제인 것을 특징으로 하는 아토피 증상 완화용 조성물.
The method according to claim 1,
Wherein the composition for alleviating atopic symptoms is a tablet, a capsule, a pill or a solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140152773A KR101738605B1 (en) | 2014-11-05 | 2014-11-05 | A composition comprising medical herbs for improving skin problem and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140152773A KR101738605B1 (en) | 2014-11-05 | 2014-11-05 | A composition comprising medical herbs for improving skin problem and manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160053557A KR20160053557A (en) | 2016-05-13 |
KR101738605B1 true KR101738605B1 (en) | 2017-05-22 |
Family
ID=56023390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140152773A KR101738605B1 (en) | 2014-11-05 | 2014-11-05 | A composition comprising medical herbs for improving skin problem and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101738605B1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI798219B (en) * | 2017-06-30 | 2023-04-11 | 南韓商愛茉莉太平洋股份有限公司 | Use of fermented mentha arvensis extract in manufacturing composition for caring damages of skin cells by microdust, enhancing skin barrier, and anti-aging or anti-inflammation |
CN108434342A (en) * | 2018-03-28 | 2018-08-24 | 张彦波 | A kind of Chinese medicine composition for treating psoriasis |
KR102107194B1 (en) * | 2018-09-10 | 2020-05-06 | 주식회사 코리아나화장품 | Cosmetic Composition For Preventing Hair Loss Containing Arctium Lappa Seed Extract |
KR102381251B1 (en) * | 2020-11-11 | 2022-03-31 | 차혜영 | Cosmetic composition for anti-oxidation, skin moisturizing, or improving of acne skin or skin trouble containing complex extract of Eriobotryae Folium |
KR102514319B1 (en) * | 2023-01-05 | 2023-03-27 | 황만기 | Manufacturing method for external composition of improving skin disease |
-
2014
- 2014-11-05 KR KR1020140152773A patent/KR101738605B1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
논문1: 동의생리병리학회지 |
Also Published As
Publication number | Publication date |
---|---|
KR20160053557A (en) | 2016-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101738605B1 (en) | A composition comprising medical herbs for improving skin problem and manufacturing method thereof | |
CN103830535A (en) | Pharmaceutical composition for treating rhinitis as well as preparation method and application thereof | |
CN105535439A (en) | Traditional Chinese medicinal composition for treating pharyngitis and preparation method thereof | |
CN102357158A (en) | Medicament for preventing and curing avian infectious laryngotracheitis and preparation method thereof | |
CN109045120A (en) | A kind of preparation method and applications of Chinese medical extract that treating nasosinusitis and bronchitis | |
CN104189784A (en) | Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation | |
CN104398873B (en) | It is a kind of for Chinese medicine preparation of external piles and preparation method thereof | |
CN103432466B (en) | Female pelvic inflammatory disease treatment traditional Chinese medicine composition and preparation method thereof | |
CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
CN105597011A (en) | Method for preparing traditional Chinese medicine composition for treating acute or chronic rhinitis | |
CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
WO2015149391A1 (en) | Preparation of traditional chinese medicine for treating chronic enteritis and preparation method therefor | |
CN104173812A (en) | Pharmaceutical composition for treating blood-heat bleeding type acute idiopathic thrombocytopenic purpura and preparation method of pharmaceutical composition | |
CN116211933B (en) | Anticoccidial traditional Chinese medicine composition and application thereof | |
WO2015149395A1 (en) | Preparation of traditional chinese medicine for treating chronic gastritis and preparation method therefor | |
CN103623109A (en) | Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof | |
KR20130014768A (en) | Oriental medicine composition for chidren's atopic dermatitis and manufacturing method thereof | |
CN102145092B (en) | Chinese medical composition capable of dispelling wind and relieving fever and preparation method | |
CN106728092B (en) | Yi medicine composition | |
CN106309636B (en) | Pharmaceutical composition for uterine bleeding | |
CN105770552A (en) | Chinese herba preparation containing folium artemisiae argyi and used for treating prostatitis and preparing method thereof | |
CN105287863A (en) | Pharmaceutical composition for curing DN (Diabetic Nephropathy) and preparation method of pharmaceutical composition | |
CN104474467A (en) | Traditional Chinese medicine composition for treating Qi-stagnation and blood stasis type dysmenorrheal and preparation method of traditional Chinese medicine composition | |
CN105267758A (en) | Traditional Chinese medicine composition for treating folliculitis | |
CN103263641A (en) | Pharmaceutical composition for nursing and preventing postoperative recurrence of endometriosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |